University of Nebraska Medical Center

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol, VantAI Pair Technologies In Pr

Merck & Co. Inc. ’s Kim Folander believes collaboration between big pharma and academic or institutional researchers may take on an increasingly important role in pipeline expansion as the competitio

IN VITRO DIAGNOSTICS Interleukin Genetics Inc. New York University New York University School of Medicine Interleukin Genetics, NYU School of Medicine to develop genetic test for OA Interleukin Ge

Investments for start-ups seeking their first infusion of venture capital continue to be scarce as venture firms seek later-stage opportunities and liquidity to improve their own chances of raising ne